v3.25.1
INVESTMENTS AND FAIR VALUE DISCLOSURES - Schedule of Components of the Company Investment (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Preferred equity investment, at fair value $ 268,263 $ 267,169
Equity investments in the Company’s products, at fair value 73,276 96,956
Equity investments in the Company’s products, equity method 62,252 63,465
Loans and deferred purchase price receivable, at amortized cost (includes $48,586 and $48,094 of investments in the Company’s products, respectively) 54,643 54,186
Investments in the Company’s CLOs, at fair value 7,702 5,169
Total 466,136 486,945
Investments in Company's products    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Loans and deferred purchase price receivable, at amortized cost (includes $48,586 and $48,094 of investments in the Company’s products, respectively) $ 48,586 $ 48,094